SB 175 - AS INTRODUCED
2019 SESSION
19-0182
01/04
SENATE BILL 175
AN ACT relative to qualifying medical conditions for therapeutic cannabis.
SPONSORS: Sen. Reagan, Dist 17; Rep. Roy, Rock. 32
COMMITTEE: Health and Human Services
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill changes the definition of qualifying medical condition for the purposes of the law governing the use of cannabis for therapeutic purposes.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
19-0182
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
AN ACT relative to qualifying medical conditions for therapeutic cannabis.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Use of Cannabis for Therapeutic Purposes; Definitions; Qualifying Medical Conditions. Amend RSA 126-X:1, IX to read as follows:
IX.[(a)] "Qualifying medical condition" means [the presence of:
(1) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, Ehlers-Danlos syndrome, or one or more injuries or conditions that has resulted in one or more qualifying symptoms under subparagraph (2); and
(2) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms; or
(b) "Qualifying medical condition" also means:
(1) Moderate to severe chronic pain.
(2) Severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.
(3) Moderate or severe post-traumatic stress disorder] any condition for which treatment is determined to be necessary by a provider.
2 Effective Date. This act shall take effect 60 days after its passage.
| Date | Body | Type |
|---|---|---|
| March 12, 2019 | Senate | Hearing |
| March 27, 2019 | Senate | Floor Vote |
| Senate | Floor Vote | |
| Jan. 8, 2020 | Senate | Floor Vote |
Jan. 8, 2020: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 01/08/2020; SJ 1
: Committee Report: Inexpedient to Legislate
Jan. 8, 2020: Committee Report: Inexpedient to Legislate, 01/08/2020; SC 47
March 27, 2019: Rereferred to Committee, MA, VV; 03/27/2019; SJ 10
March 27, 2019: Special Order to the beginning of the regular calendar, Without Objection, MA; 03/27/2019; SJ 10
March 27, 2019: Committee Report: Rereferred to Committee, 03/27/2019; SC 15
March 12, 2019: Hearing: 03/12/2019, Room 101, LOB, 02:00 pm; SC 13
Jan. 3, 2019: Introduced 01/03/2019 and Referred to Health and Human Services; SJ 4